Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Thu, 11.01.2024
Gurit Holding AG
Gurit Holding AG
/ Key word(s): Rating/Sustainability
Gurit receives gold award for sustainability performance
11.01.2024 / 17:45 CET/CEST
Zurich, January 11, 2024
Gurit (SIX Swiss Exchange: GURN) has been awarded a gold medal for its sustainability performance from EcoVadis, one of the world’s largest and most trusted [ … ]
Thu, 11.01.2024
Southey Capital Ltd
THIS OFFER IS SUBJECT TO ENGLISH LAW. THIS OFFER IS NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT.
12 January 2024
ANNOUNCEMENT OF INVITATION TO VOLUNTARY TENDER OFFER TO THE HOLDERS OF YANDEX N.V. ORD REG ISSUED BY YANDEX N.V. – IS [ … ]
Thu, 11.01.2024
Amprion GmbH
Dortmund, Thursday, 11 January 2024Science Based Target initiative confirms Amprion's CO2 reduction targetsThe CO2 reduction targets of the transmission system operator Amprion are in line with the Paris Climate Agreement. This is the result of the scientific review of the reduction targets for Scopes 1 to 3 by the Science Based Target initiative ( [ … ]
Thu, 11.01.2024
Alzchem Group AG
EQS-Media / 11.01.2024 / 15:28 CET/CEST
Long-Covid: New clinical studies show high efficacy of creatine supplementation
Creatine is a natural, endogenous substance that plays a central role as an energy transporter and buffer in every cell. It is an essential component of cellular energy metabolism and is therefore important for all energy-i [ … ]
Thu, 11.01.2024
Mainz BioMed N.V.
Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium
BERKELEY, US – MAINZ, Germany – January 11, 2024 — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in early cancer detection, re-affirms its collaboration with TestDNA at the upcoming 1 [ … ]
Thu, 11.01.2024
P&P Group
London, 11 January 2024 - P&P London, a prominent property investor and developer, is expanding its portfolio with additional properties strategically located in prime areas of the British capital. The acquisitions include flats and a historic pub, contributing attractive new locations to the company's growing portfolio. Michael Peter, the Mana [ … ]
Thu, 11.01.2024
Advanced Blockchain AG
Advanced Blockchain AG: Blockchain business models benefit from the approval of the Bitcoin Spot ETF
January 11, 2024 - Yesterday evening, January 10, 2024, the Securities and Exchange Commission (SEC) granted approval for the first Exchange Traded Fund (ETF) for Bitcoin spot trading. Advanced Blockchain AG ("AB", Scale Frankfurt, Primary Market [ … ]
Thu, 11.01.2024
Carl Zeiss Meditec AG
U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.
DUBLIN, CA (USA) / JENA, Germany | January 11, 2024 | Carl Zeiss Meditec AG
ZEISS Medical Technology announced today tha [ … ]
Thu, 11.01.2024
Commerzbank Aktiengesellschaft
Partnership combines Commerzbank’s strong position serving small and medium size German businesses and Global Payments’ leading payment technology and software capabilities
Joint venture will offer digital payment services for merchants
Frankfurt/ Main, Atlanta, 11 January 2024 – Commerzbank (FRA: CBK) and Global Payments (NYSE: GPN), a leading wo [ … ]
Thu, 11.01.2024
Heliad AG
FINN raises EUR 100m in Series C to accelerate the growth of its electric fleet, with Heliad AG also increasing its commitment.
Germany, Frankfurt, January 11, 2024 – Heliad AG (Stock ticker A7A, ISIN DE0001218063) is pleased to announce that our portfolio company FINN raised EUR 100 million in their Series C. Expressing our confidence in FINN [ … ]